The Role of mTOR Signaling as a Therapeutic Target in CancerN. V. Popova, Manfred Jücker|International Journal of Molecular Sciences|2021Cited by 259
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cellsNicole Grabinski, Manfred Jücker|Molecular Cancer|2012Cited by 121
Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4Astrid Grottke, Manfred Jücker|PLoS ONE|2016Cited by 99
Combined targeting of AKT and mTOR using MK‐2206 and RAD001 is synergistic in the treatment of cholangiocarcinomaFlorian Ewald, Manfred Jücker|International Journal of Cancer|2013Cited by 86
Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular CarcinomaFlorian Ewald, Manfred Jücker|Journal of Cancer|2015Cited by 42